Genetic variants of <it>NOXA</it> and <it>MCL1</it> modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
<p>Abstracts</p> <p>Background</p> <p>The cooperation between phorbol 12-myristate 13-acetate induced protein 1 (NOXA) and myeloid cell leukemia 1 (MCL1) is critical in the intrinsic apoptotic pathway. Human papillomavirus 16 (HPV16), by inducing p53 and pRb-E2F degrada...
Main Authors: | Zhou Ziyuan, Sturgis Erich M, Liu Zhensheng, Wang Li-E, Wei Qingyi, Li Guojun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/159 |
Similar Items
-
The Role of Noxa/MCL-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment
by: Lee, June Young
Published: (2015) -
Noxa/Mcl-1 Balance Regulates Susceptibility of Cells to Camptothecin-Induced Apoptosis
by: Yide Mei, et al.
Published: (2007-10-01) -
Tumor-Specific Cell Death Induction by Noxa Overexpression for Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment
by: Maxim, Nicolas T, Mr.
Published: (2016) -
MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation
by: Seiji Arai, et al.
Published: (2020-06-01) -
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA
by: David J. Mallick, et al.
Published: (2020-08-01)